Request for Covid-19 Impact Assessment of this Report
The key regions considered for the Global Non-steroidal Anti-inflammatory Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America emerged as the market leader. Some of the primary reasons driving the industry's growth are the existence of a large number of manufacturers and strategic efforts implemented by market participants. Furthermore, the rising prevalence of chronic pain and arthritis is expected to drive growth throughout the projected period. During the projection period, Asia-Pacific is predicted to be the fastest-growing region. The area's rise is ascribed to causes such as an ageing population, an increase in the prevalence of chronic pain, migraines, and headaches, as well as an increase in product approvals and launches in the region.
Major market player included in this report are:
Pfizer Inc.
Bayer AG
GSK plc
Dr. Reddy’s Laboratories Ltd
Viatris Inc
Teva Pharmaceutical Industries Ltd.
Johnson And Johnson Services, Inc.
Merck & Co., Inc.
Becton Dickinson & Company
Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.)
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Disease Indication:
Arthritis
Migraine
Ophthalmic Diseases
Others
By Route of Administration:
Oral
Topical
Others
By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Non-steroidal Anti-inflammatory Drugs Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Non-steroidal Anti-inflammatory Drugs Market, by Region, 2020-2028 (USD Billion)
1.2.2. Non-steroidal Anti-inflammatory Drugs Market, by Disease Indication, 2020-2028 (USD Billion)
1.2.3. Non-steroidal Anti-inflammatory Drugs Market, by Route of Administration, 2020-2028
1.2.4. Non-steroidal Anti-inflammatory Drugs Market, by Distribution Channel, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Non-steroidal Anti-inflammatory Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Non-steroidal Anti-inflammatory Drugs Market Dynamics
3.1. Non-steroidal Anti-inflammatory Drugs Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Rising prevalence of chronic pain across the globe
3.1.1.2. Increasing demand for OTC NSAIDs and the rising adoption of NSAIDs
3.1.2. Market Challenges
3.1.2.1. Side effects of the drugs
3.1.3. Market Opportunities
3.1.3.1. Technological improvements in Non-steroidal Anti-inflammatory Drugs
Chapter 4. Global Non-steroidal Anti-inflammatory Drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Non-steroidal Anti-inflammatory Drugs Market, by Disease Indication
6.1. Market Snapshot
6.2. Global Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, Performance - Potential Analysis
6.3. Global Non-steroidal Anti-inflammatory Drugs Market Estimates & Forecasts by Disease Indication 2018-2028 (USD Billion)
6.4. Non-steroidal Anti-inflammatory Drugs Market, Sub Segment Analysis
6.4.1. Arthritis
6.4.2. Migraine
6.4.3. Ophthalmic Diseases
6.4.4. Others
Chapter 7. Global Non-steroidal Anti-inflammatory Drugs Market, by Route of Administration
7.1. Market Snapshot
7.2. Global Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, Performance - Potential Analysis
7.3. Global Non-steroidal Anti-inflammatory Drugs Market Estimates & Forecasts by Route of Administration 2018-2028 (USD Billion)
7.4. Non-steroidal Anti-inflammatory Drugs Market, Sub Segment Analysis
7.4.1. Oral
7.4.2. Topical
7.4.3. Others
Chapter 8. Global Non-steroidal Anti-inflammatory Drugs Market, by Distribution Channel
8.1. Market Snapshot
8.2. Global Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, Performance - Potential Analysis
8.3. Global Non-steroidal Anti-inflammatory Drugs Market Estimates & Forecasts by Distribution Channel 2018-2028 (USD Billion)
8.4. Non-steroidal Anti-inflammatory Drugs Market, Sub Segment Analysis
8.4.1. Hospital Pharmacy
8.4.2. Retail Pharmacy
8.4.3. Online Pharmacy
Chapter 9. Global Non-steroidal Anti-inflammatory Drugs Market, Regional Analysis
9.1. Non-steroidal Anti-inflammatory Drugs Market, Regional Market Snapshot
9.2. North America Non-Steroidal Anti-inflammatory Drugs Market
9.2.1. U.S. Non-steroidal Anti-inflammatory Drugs Market
9.2.1.1. Disease Indication breakdown estimates & forecasts, 2018-2028
9.2.1.2. Route of Administration breakdown estimates & forecasts, 2018-2028
9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2018-2028
9.2.2. Canada Non-steroidal Anti-inflammatory Drugs Market
9.3. Europe Non-steroidal Anti-inflammatory Drugs Market Snapshot
9.3.1. U.K. Non-steroidal Anti-inflammatory Drugs Market
9.3.2. Germany Non-steroidal Anti-inflammatory Drugs Market
9.3.3. France Non-steroidal Anti-inflammatory Drugs Market
9.3.4. Spain Non-steroidal Anti-inflammatory Drugs Market
9.3.5. Italy Non-steroidal Anti-inflammatory Drugs Market
9.3.6. Rest of Europe Non-steroidal Anti-inflammatory Drugs Market
9.4. Asia-Pacific Non-steroidal Anti-inflammatory Drugs Market Snapshot
9.4.1. China Non-steroidal Anti-inflammatory Drugs Market
9.4.2. India Non-steroidal Anti-inflammatory Drugs Market
9.4.3. Japan Non-steroidal Anti-inflammatory Drugs Market
9.4.4. Australia Non-steroidal Anti-inflammatory Drugs Market
9.4.5. South Korea Non-steroidal Anti-inflammatory Drugs Market
9.4.6. Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market
9.5. Latin America Non-steroidal Anti-inflammatory Drugs Market Snapshot
9.5.1. Brazil Non-steroidal Anti-inflammatory Drugs Market
9.5.2. Mexico Non-steroidal Anti-inflammatory Drugs Market
9.6. Rest of The World Non-steroidal Anti-inflammatory Drugs Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Pfizer Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Disease Indication Summary
10.2.1.5. Recent Developments
10.2.2. Bayer AG
10.2.3. GSK plc
10.2.4. Dr. Reddy’s Laboratories Ltd
10.2.5. Viatris Inc
10.2.6. Teva Pharmaceutical Industries Ltd.
10.2.7. Johnson And Johnson Services, Inc.
10.2.8. Merck & Co., Inc.
10.2.9. Becton Dickinson & Company
10.2.10. Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.)
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
TABLE 1. Global Non-steroidal Anti-inflammatory Drugs Market, report scope
TABLE 2. Global Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by Region 2018-2028 (USD Billion)
TABLE 3. Global Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by Disease Indication 2018-2028 (USD Billion)
TABLE 4. Global Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by Route of Administration 2018-2028 (USD Billion)
TABLE 5. Global Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by Distribution Channel 2018-2028 (USD Billion)
TABLE 6. Global Non-steroidal Anti-inflammatory Drugs Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 7. Global Non-steroidal Anti-inflammatory Drugs Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 8. Global Non-steroidal Anti-inflammatory Drugs Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 9. Global Non-steroidal Anti-inflammatory Drugs Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 10. Global Non-steroidal Anti-inflammatory Drugs Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 11. Global Non-steroidal Anti-inflammatory Drugs Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 12. Global Non-steroidal Anti-inflammatory Drugs Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 13. Global Non-steroidal Anti-inflammatory Drugs Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 14. Global Non-steroidal Anti-inflammatory Drugs Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 15. Global Non-steroidal Anti-inflammatory Drugs Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 16. U.S. Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 17. U.S. Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 18. U.S. Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 19. Canada Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 20. Canada Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 21. Canada Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 22. UK Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 23. UK Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 24. UK Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 25. Germany Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 26. Germany Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 27. Germany Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 28. RoE Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 29. RoE Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 30. RoE Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 31. China Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 32. China Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 33. China Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 34. India Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 35. India Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 36. India Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 37. Japan Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 38. Japan Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 39. Japan Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 40. RoAPAC Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 41. RoAPAC Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 42. RoAPAC Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 43. Brazil Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 44. Brazil Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 45. Brazil Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 46. Mexico Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 47. Mexico Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 48. Mexico Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 49. RoLA Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 50. RoLA Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 51. RoLA Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 52. Row Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 53. Row Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 54. Row Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 55. List of secondary sources, used in the study of global Non-steroidal Anti-inflammatory Drugs Market
TABLE 56. List of primary sources, used in the study of global Non-steroidal Anti-inflammatory Drugs Market
TABLE 57. Years considered for the study
TABLE 58. Exchange rates considered
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...